The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Burgess Daniel D since year 2005.
The trader's CIK number is 1239650.
At the time of this reporting, Burgess Daniel D is the Director of Cidara Therapeutics, Inc. .
(stock ticker symbol CDTX).
See this page for all insider trading activities at Cidara Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-04-20||CDTX||Cidara Therapeutics, Inc.||Buy||3,000||16.00||48,000|
|2013-06-03||SNTS||Santarus Inc||Option Ex||8,000||3.00||24,000|
|2013-05-01||SNTS||Santarus Inc||Option Ex||8,000||3.00||24,000|
|2013-04-01||SNTS||Santarus Inc||Option Ex||8,000||2.09||16,720|
|2013-03-01||SNTS||Santarus Inc||Option Ex||8,000||1.18||9,440|
|2013-02-01||SNTS||Santarus Inc||Option Ex||8,000||1.18||9,440|
|2007-02-14||HEPH||Hollis Eden Pharmaceuticals Inc /de/||Sale||2,250||5.50||12,375|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Burgess Daniel D (Director of Cidara Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.